Affinity Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$399K Sell
345
-15
-4% -$17.7K 0.17% 106
2026
Q2
$432K Hold
360
– – 0.22% 103
2026
Q1
$331K Hold
360
– – 0.21% 107
2025
Q4
$387K Hold
360
– – 0.26% 95
2025
Q3
$275K Hold
360
– – 0.19% 112
2025
Q2
$281K Hold
360
– – 0.21% 111
2025
Q1
$297K Hold
360
– – 0.24% 110
2024
Q4
$278K Hold
360
– – 0.23% 109
2024
Q3
$319K Buy
+360
New +$324K 0.22% 109

Other funds holding LLY

Affinity Investment Advisors's LLY Position: Q3 2026 in Review

Affinity Investment Advisors reduced its Eli Lilly (LLY) stake by 4.2% in Q3 2026, selling an estimated $17.7K and leaving 345 shares worth $399K. The position accounts for 0.17% of the portfolio, ranked #106.

Affinity Investment Advisors first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $432K in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Affinity Investment Advisors held 345 shares of Eli Lilly worth $399K as of Q3 2026.
  • Affinity Investment Advisors sold 15 Eli Lilly shares in Q3 2026, an estimated $17.7K.
  • Eli Lilly made up 0.17% of Affinity Investment Advisors's portfolio in Q3 2026, its #106 holding.
  • Affinity Investment Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
  • Affinity Investment Advisors's Eli Lilly position peaked at $432K in Q2 2026.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Affinity Investment Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.